Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Tax Provisions (2017 - 2025)

Historic Tax Provisions for ProPhase Labs (PRPH) over the last 6 years, with Q3 2025 value amounting to -$157000.0.

  • ProPhase Labs' Tax Provisions rose 9374.0% to -$157000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year increase of 24771.78%. This contributed to the annual value of $7.2 million for FY2024, which is 21955.8% up from last year.
  • Per ProPhase Labs' latest filing, its Tax Provisions stood at -$157000.0 for Q3 2025, which was up 9374.0% from $779000.0 recorded in Q2 2025.
  • ProPhase Labs' 5-year Tax Provisions high stood at $14.6 million for Q4 2024, and its period low was -$2.9 million during Q4 2023.
  • Its 4-year average for Tax Provisions is $446000.0, with a median of -$815500.0 in 2023.
  • The largest annual percentage gain for ProPhase Labs' Tax Provisions in the last 5 years was 59951.96% (2024), contrasted with its biggest fall of 1842857.14% (2024).
  • Over the past 4 years, ProPhase Labs' Tax Provisions (Quarter) stood at -$2.7 million in 2022, then decreased by 6.16% to -$2.9 million in 2023, then surged by 599.52% to $14.6 million in 2024, then crashed by 101.08% to -$157000.0 in 2025.
  • Its last three reported values are -$157000.0 in Q3 2025, $779000.0 for Q2 2025, and $14.6 million during Q4 2024.